Prevention of Lymphorrhea by Lanreotide in Axillary Dissection for Breast Cancer

NCT00630695 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

148

Enrollment

OTHER

Sponsor class

Conditions

Lymphocele

Interventions

DRUG: Lanreotide LP 90
DRUG: Placebo lanreotide

Sponsor

University Hospital, Limoges

Collaborators

[object Object]